Does renin-angiotensin system inhibition have impacts on muscle mass and bone mineral density in heart failure patients?

Satoshi KatanoToshiyuki YanoMasaki ShimizuKatsuhiko OhoriHidemichi KouzuMasayuki KoyamaRyohei NagaokaTakuya InoueYuhei TakamuraTomoyuki IshigoHiroyuki TakashimaMasaki KatayoseHirofumi OhnishiTetsuji Miura

Published in: ESC heart failure (2021)

Renin-angiotensin system inhibition is associated with a lower prevalence of muscle wasting in HF patients independently of established risk factors.

Keyphrases

bone mineral density
risk factors
ejection fraction
postmenopausal women
end stage renal disease
body composition
chronic kidney disease
newly diagnosed
skeletal muscle
prognostic factors
atrial fibrillation